[Withdrawal in opiate addicts in an internal medicine hospital unit] NLM AIDSLINE Important note: Information in this article was accurate in 1996. The state of the art may have changed since the publication date.

Click here to return to AIDSLINE main menu
DonateNow
Print this Article


[Withdrawal in opiate addicts in an internal medicine hospital unit]

Bull Acad Natl Med. 1995 Oct;179(7):1335-51; discussion 1351-4. Unique Identifier : AIDSLINE MED/96151625
Cremer GA; Boissonnas A; Service de Medecine Interne, Groupe hospitalier Cochin, Paris.

Abstract: Withdrawal of opiates drug addicts in Internal Medicine is unusual in France. Four main preliminary conditions are requested: 1--Drug addict preparation and self motivation, 2--Inter and intra institution team collaboration, 3--Opening the hospital towards community agencies, 4--Hospital staff recruited on volunteer basis. Within two years (1992-1993), 210 opiates drug addicts were hospitalized for withdrawal. Two third were males, median age was 27, median years of addiction was 7. Thirty percent were seropositive for HIV, 70% for HCV. Hospitalisation lasted 7 days for heroin addicts and 10 days for morphin, codein or buprenorphin addicts. Successful withdrawn was observed for 70% patients but six months after withdrawal, only 15% remained abstinent.
Keywords: Adult Analgesics, Opioid Buprenorphine Codeine Comparative Study English Abstract Female France Heroin Dependence/THERAPY Hospital Departments Hospitalization Human Internal Medicine Male Morphine Dependence/THERAPY Narcotic Dependence/*THERAPY Recurrence Time Factors JOURNAL ARTICLEKWDadultanalgesics,opioidbuprenorphinecodeinecomparativestudyenglishabstractfemalefranceheroindependence/therapyhospitaldepartmentshospitalizationhumaninternalmedicinemalemorphinedependence/therapynarcoticdependence/KWDtherapyrecurrencetimefactorsjournalarticle
960530
M9651022

Copyright © 1996 - National Library of Medicine. Reproduced under license with the National Library of Medicine, Bethesda, MD.

AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted funding from Boehringer Ingelheim, Bridgestone/Firestone Charitable Trust, Bristol-Myers Squibb Company, Elton John AIDS Foundation, Gill Foundation, the National Library of Medicine, Quest Diagnostics, Roche and Trimeris, and donations from users like you. Always watch for outdated information. This article first appeared in 1996. This material is designed to support, not replace, the relationship that exists between you and your doctor.

AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.

Copyright ©1980, 1996. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content. .